首页> 外文OA文献 >Preclinical Efficacy and Safety of the Novel Antidiabetic, Antiobesity MetAP2 Inhibitor ZGN-1061

【2h】

Preclinical Efficacy and Safety of the Novel Antidiabetic, Antiobesity MetAP2 Inhibitor ZGN-1061

机译：新型抗糖尿病，抗特性Metap2抑制剂ZGN-1061的临床前疗效和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Bryan F. Burkey; Niel C. Hoglen; Philip Inskeep; Margaret Wyman; Thomas E. Hughes; James E. Vath;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Preclinical Efficacy and Safety of the Novel Antidiabetic, Antiobesity MetAP2 Inhibitor ZGN-1061 [J] . Burkey Bryan F., Hoglen Niel C., Inskeep Philip, The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics . 2018,第2期

机译：新型抗糖尿病，抗特性Metap2抑制剂ZGN-1061的临床前疗效和安全性
2. Antidiabetic potential of polyherbal formulation DB14201: Preclinical development, safety and efficacy studies [J] . Pillaii Geetha Krishnan Gopalakrishna, Bharate Sonali S., Awasthi Anshumali, Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs . 2017,第期

机译：聚母配方DB14201的抗糖尿病潜力：临床前发育，安全性和疗效研究
3. An update on the safety and efficacy of oral antidiabetic drugs: DPP-4 inhibitors and SGLT-2 inhibitors [J] . Elizabeth Mary Lamos, Maka Hedrington, Stephen N Davis Expert opinion on drug safety . 2019,第7a12期

机译：口腔抗糖尿病药物安全性和有效性的更新：DPP-4抑制剂和SGLT-2抑制剂
4. CAT-02-106, a Site-Specifically Conjugated Anti-CD22 Antibody Bearing an MDRl-Resistant Maytansine Payload, Yields Excellent Efficacy and Safety in Preclinical Models [C] . Robyn Μ. Barfield, Penelope Μ. Drake, Adam Carlson, Protein Engineering Summit. . 2018

机译：CAT-02-106，一种耐受MDRL抗性Maytansine有效载荷的位点特异性缀合的抗CD22抗体，在临床前模型产生优异的功效和安全性
5. Antiobesity and antidiabetic activity of P. balsamifera, its active Salicortin, and L. laricina, medicinal plants from the traditional pharmacopoeia of the James Bay Cree. [D] . Harbilas, Despina. 2012

机译：P. balsamifera，其活性Salicortin和L. laricina的抗肥胖和抗糖尿病活性是James Bay Cree传统药典的药用植物。
6. Efficacy and safety assessment of basal supported oral therapy (BOT) with insulin glargine in a real-life clinical setting stratified by concomitant orally administered antidiabetic agent (OAD) regimens including dipeptidyl peptidase-4 inhibitor (DPP-4i): subanalysis of the ALOHA2 study drug-use surveillance in Japan [O] . Shoko Tsukube, Takashi Kadowaki, Masato Odawara 2016

机译：甘精胰岛素在现实生活中的基础支持口服治疗（BOT）的疗效和安全性评估按口服降糖药（OAD）方案（包括二肽基肽酶-4抑制剂（DPP-4i））进行分层：ALOHA2的亚分析研究日本的毒品使用监视
7. Efficacy and safety assessment of basal supported oral therapy (BOT) with insulin glargine in a real-life clinical setting, stratified by concomitant orally administered antidiabetic agent (OAD) regimens including dipeptidyl peptidase-4 inhibitor (DPP-4i): subanalysis of the ALOHA2 study, drug-use surveillance in Japan [O] . Shoko Tsukube, Takashi Kadowaki, Masato Odawara 2016

机译：基础支持的口服治疗（BOT）在真实临床环境中具有胰岛素甘油的疗效和安全评估，通过伴随口服给药的抗糖尿病（OAD）方案分层，包括二肽基肽酶-4抑制剂（DPP-4i）：Aloha2的细胞分析研究，日本的药用监测

Preclinical Efficacy and Safety of the Novel Antidiabetic, Antiobesity MetAP2 Inhibitor ZGN-1061

著录项

引文网络

相似文献

相关主题

期刊订阅